<DOC>
<DOCNO>EP-0648270</DOCNO> 
<TEXT>
<INVENTION-TITLE>
CLONING OF GENE ENCODING THE GP28.5 PROTEIN OF TOXOPLASMA GONDII; PEPTIDE FRAGMENTS OF SAID PROTEIN AND THEIR APPLICATIONS
</INVENTION-TITLE>
<CLASSIFICATIONS>C12N1509	G01N33569	C12N1530	C07K1900	A61K3900	C07K1618	C12P2102	C12N121	C07K1600	C07K14435	C07K1600	A61P3100	C07K1444	C12N1530	G01N33569	C07K1620	C12N121	C12N1509	A61K39002	C12P2102	G01N3353	A61K3900	C07K1900	A61K39002	C07K1445	G01N3353	A61P3100	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>C12N	G01N	C12N	C07K	A61K	C07K	C12P	C12N	C07K	C07K	C07K	A61P	C07K	C12N	G01N	C07K	C12N	C12N	A61K	C12P	G01N	A61K	C07K	A61K	C07K	G01N	A61P	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>C12N15	G01N33	C12N15	C07K19	A61K39	C07K16	C12P21	C12N1	C07K16	C07K14	C07K16	A61P31	C07K14	C12N15	G01N33	C07K16	C12N1	C12N15	A61K39	C12P21	G01N33	A61K39	C07K19	A61K39	C07K14	G01N33	A61P31	</CLASSIFICATIONS-FOURTH>
<APPLICANTS>
<APPLICANT-NAME>
INST NAT SANTE RECH MED
</APPLICANT-NAME>
<APPLICANT-NAME>
PASTEUR INSTITUT
</APPLICANT-NAME>
<APPLICANT-NAME>
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
</APPLICANT-NAME>
<APPLICANT-NAME>
INSTITUT PASTEUR DE LILLE
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
CAPRON ANDRE
</INVENTOR-NAME>
<INVENTOR-NAME>
CESBRON MARIE-FRANCE
</INVENTOR-NAME>
<INVENTOR-NAME>
MAES PIERRETTE
</INVENTOR-NAME>
<INVENTOR-NAME>
MERCIER CORINNE
</INVENTOR-NAME>
<INVENTOR-NAME>
TARTAR ANDRE
</INVENTOR-NAME>
<INVENTOR-NAME>
CAPRON, ANDRE
</INVENTOR-NAME>
<INVENTOR-NAME>
CESBRON, MARIE-FRANCE
</INVENTOR-NAME>
<INVENTOR-NAME>
MAES, PIERRETTE
</INVENTOR-NAME>
<INVENTOR-NAME>
MERCIER, CORINNE
</INVENTOR-NAME>
<INVENTOR-NAME>
TARTAR, ANDRE
</INVENTOR-NAME>
</INVENTORS>
<CLAIMS>
Nucleic acid fragment, 
characterised in that
 it
comprises the sequence SEQ. ID. NO:1.
Nucleic acid fragment encoding a polypeptide comprising
at least one epitope of the toxoplasma GP28.5 antigen,


characterised in that
 the polypeptide is constituted by the
C-terminal 8 to 15 amino acids of the sequence SEQ. ID.

NO:2.
Peptide fragment constituting an epitope of the
toxoplasma GP28.5 antigen, 
characterised in that
 it is
constituted by the C-terminal 8 to 15 amino acids of the

sequence SEQ. ID. NO:2.
Process for the production of a peptide fragment
according to claim 3, which process is 
characterised in that

it comprises a step during whichan eukaryotic or prokaryotic
cell transformed by a nucleic acid fragment according to

claim 2 is cultured.
Antigen composition, 
characterised in that
 it comprises
at least one peptide fragment according to claim 3.
Process for the preparation of anti-GP28.5 antibodies,

characterised in that
 it comprises a step during which an
animal is immunised with an antigen composition according to

claim 5.
Use of an antigen composition according to claim 5 for
the production of diagnostic reagents for toxoplasmosis. 
Use of an antigen composition according to claim 5 for
the production of anti-toxoplasma vaccines.
</CLAIMS>
</TEXT>
</DOC>
